Concepedia

Author

Vibeke Strand

Stanford UniversityORCID

Also Known As

Bruce Kirkham, J. Smolen, Jon Geirsson, L. Gossec, P. Taylor, Patrick Durez, Strand, V, Strand, V., Strand, Vibeke, V Strand

764

Publications

34.8K

Citations

92

H-Index

132

Concepts

All Affiliations

Stanford UniversityJohns Hopkins UniversityPalo Alto UniversityUniversity of TorontoUniversity of Washington
VS

About

Vibeke Strand is an author at Stanford University specializing in medicine, rheumatology, and clinical trials.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

31

58

4.6K

2

Health Sciences

14

15

1.3K

3

Engineering

2

2

130

4

Public Health

2

2

199

5

Nursing

1

1

150

Vibeke Strand

×

272

Publications

25.5K

Citations

79

H-Index

YearCitations

American college of rheumatology preliminary definition of improvement in rheumatoid arthritis

David T. Felson, Jennifer J. Anderson, Maarten Boers,

Arthritis & Rheumatism

1995

2.8K

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

David T. Felson, Josef S Smolen, George A. Wells,

Arthritis & Rheumatism

2011

1K

OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.

D. van der Heijde, Roy D. Altman, Jennifer J. Anderson,

Osteoarthritis and Cartilage

2004

817

Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0

Maarten Boers, John Kirwan, George A. Wells,

Journal of Clinical Epidemiology

2014

761

Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty‐two–week, phase III, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group study

Edward Keystone, Désirée van der Heijde, David Mason,

Arthritis & Rheumatism

2008

569

OMERACT: An international initiative to improve outcome measurement in rheumatology

Peter Tugwell, Maarten Boers, Peter Brooks,

Trials

2007

526

Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).

Daniel E. Furst, Michael Schiff, Roy Fleischmann,

PubMed

2003

494

Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial

Josef S Smolen, R. B. M. Landewé, Philip J. Mease,

Annals of the Rheumatic Diseases

2008

489

Novel evidence‐based systemic lupus erythematosus responder index

Richard Furie, Michelle Petri, Daniel J. Wallace,

Arthritis Care & Research

2009

468

Minimal clinically important differences: review of methods.

George A. Wells, Dorcas Beaton, Beverley Shea,

PubMed

2001

383

Page 1